S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CELZ Creative Medical Technology Holdings Inc

2.59

0.19 (7.92%)

Jan 24 2025 - Closed

Delayed by 15 minutes

Form 424B5 - Prospectus [Rule 424(b)(5)]

null

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technology Holdings Inc News

Form 8-K - Current report
Thursday 26 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (3 months ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Friday 8 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 23 October 2024 (3 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Wednesday 23 October 2024 (3 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Friday 4 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 9 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 25 July 2024 (6 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program
Wednesday 24 July 2024 (6 months ago) • GlobeNewswire Inc.

More Creative Medical Technology Holdings Inc News Articles

MineralRite (PK)

Moon Equity (PK)

TransCode Therapeutics

NioCorp Developments

Brookmount Explorations (PK)

Tonix Pharmaceuticals

Lightwave Logic

Good Vibrations Shoes (PK)

North Bay Resources (PK)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions